Suboptimal adherence to adjuvant endocrine therapy (ET) in Brazilian women with early-stage estrogen receptor-positive (ER plus ) breast cancer

被引：0
|
作者：
Assad-Suzuki, Daniele
Resende, Heloisa
Santos, Danielle
Moura, Fernanda
Oliveira, Sulene
Shimada, Andrea
Galvao, Anna Luiza
Souza, Bruno
Castro, Amanda
Andrade, Monalisa
Beckedorff, Yuri
Magalhaes, Maria Cristina
Souza, Cristiano
Paiva, Carlos
Pereira, Daniela
Rodrigues, Angelica
Rosa, Daniela
Barroso-Sousa, Romualdo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-12-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-12-04
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Adherence to Adjuvant Endocrine Therapy and Survival Among Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
    Chanhyun Park
    Ji-Haeng Heo
    Sanica Mehta
    Sola Han
    Jennifer C. Spencer
    [J]. Clinical Drug Investigation, 2023, 43 : 167 - 176
  • [2] Adherence to Adjuvant Endocrine Therapy and Survival Among Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
    Park, Chanhyun
    Heo, Ji-Haeng
    Mehta, Sanica
    Han, Sola
    Spencer, Jennifer C.
    [J]. CLINICAL DRUG INVESTIGATION, 2023, 43 (03) : 167 - 176
  • [3] THE USE OF ADJUVANT ENDOCRINE THERAPY IN OLDER WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER (BC)
    Aapro, M.
    Crivellari, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 208 - 209
  • [4] Patterns of relapse in older women diagnosed with estrogen receptor (ER)-positive early-stage breast cancer (BC) treated with lumpectomy without adjuvant endocrine therapy (ET)
    Chadha, Manjeet
    Shao, T.
    Cate, S.
    Malamud, S.
    White, C.
    Boolbol, S. K.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2019, 8 (03) : 349 - 353
  • [5] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yan, Yi-Dan
    Fu, Jie
    Gu, Zhi-Chun
    Lu, Jin-Song
    Su, Ying-Jie
    Lin, Hou-Wen
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01) : 184 - 190
  • [6] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yi-Dan Yan
    Jie Fu
    Zhi-Chun Gu
    Jin-Song Lu
    Ying-Jie Su
    Hou-Wen Lin
    [J]. International Journal of Clinical Pharmacy, 2023, 45 : 184 - 190
  • [7] Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
    Hu, Xin
    Walker, Mark S.
    Stepanski, Edward
    Kaplan, Cameron M.
    Martin, Michelle Y.
    Vidal, Gregory A.
    Schwartzberg, Lee S.
    Graetz, Ilana
    [J]. JAMA NETWORK OPEN, 2022, 5 (08) : E2225485
  • [8] Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR plus ) breast cancer
    Foldi, Julia
    Tsagianni, Anastasia
    Salganik, Max
    Schnabel, Catherine A.
    Brufsky, Adam
    van Londen, G. J.
    Pusztai, Lajos
    Sanft, Tara
    [J]. BMC CANCER, 2023, 23 (01)
  • [9] The postmenopause: adjuvant endocrine therapy at an early stage of hormone receptor-positive breast cancer
    Brucker, S.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (08) : 847 - 851
  • [10] Race differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer.
    Hu, Xin
    Walker, Mark S.
    Stepanski, Edward
    Kaplan, Cameron
    Martin, Michelle Y.
    Vidal, Gregory A.
    Schwartzberg, Lee S.
    Graetz, Ilana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345